# Consumer Portfolio Services, Inc.: financial statements, quarterly

CPSS · Nasdaq · CIK 889609 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cpss.md) · [Financials](/companies/cpss/financials.md) · [Filings](/companies/cpss/filings.md) · [Insiders](/companies/cpss/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cpss/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [92.1](/filings/0001683168-24-007729.md) | [92.0 d](/filings/0001683168-26-001856.md) | [91.7](/filings/0001683168-25-003436.md) | [95.9](/filings/0001683168-25-005901.md) | [101](/filings/0001683168-25-008144.md) | [105 d](/filings/0001683168-26-001856.md) | [107](/filings/0001683168-26-003607.md) | [110](/filings/0001683168-26-006096.md) | [108](/filings/0001683168-25-008144.md) | [109 d](/filings/0001683168-26-001856.md) | [112](/filings/0001683168-26-003607.md) | [121](/filings/0001683168-26-006096.md) |
| Interest expense | $m | [37.9](/filings/0001683168-24-007729.md) | [40.3 d](/filings/0001683168-26-001856.md) | [42.0](/filings/0001683168-25-003436.md) | [46.7](/filings/0001683168-25-005901.md) | [50.1](/filings/0001683168-25-008144.md) | [52.5 d](/filings/0001683168-26-001856.md) | [54.9](/filings/0001683168-26-003607.md) | [58.7](/filings/0001683168-26-006096.md) | [59.1](/filings/0001683168-25-008144.md) | [59.3 d](/filings/0001683168-26-001856.md) | [60.1](/filings/0001683168-26-003607.md) | [64.3](/filings/0001683168-26-006096.md) |
| Income tax | $m | [3.8](/filings/0001683168-24-007729.md) | [2.7 d](/filings/0001683168-26-001856.md) | [2.0](/filings/0001683168-25-003436.md) | [2.0](/filings/0001683168-25-005901.md) | [2.1](/filings/0001683168-25-008144.md) | [2.2 d](/filings/0001683168-26-001856.md) | [2.1](/filings/0001683168-26-003607.md) | [2.2](/filings/0001683168-26-006096.md) | [2.2](/filings/0001683168-25-008144.md) | [2.2 d](/filings/0001683168-26-001856.md) | [2.5](/filings/0001683168-26-003607.md) | [2.8](/filings/0001683168-26-006096.md) |
| Net income | $m | [10.4](/filings/0001683168-24-007729.md) | [7.2 d](/filings/0001683168-26-001856.md) | [4.6](/filings/0001683168-25-003436.md) | [4.7](/filings/0001683168-25-005901.md) | [4.8](/filings/0001683168-25-008144.md) | [5.1 d](/filings/0001683168-26-001856.md) | [4.7](/filings/0001683168-26-003607.md) | [4.8](/filings/0001683168-26-006096.md) | [4.9](/filings/0001683168-25-008144.md) | [5.0 d](/filings/0001683168-26-001856.md) | [5.5](/filings/0001683168-26-003607.md) | [6.2](/filings/0001683168-26-006096.md) |
| Diluted EPS | $ per share | [0.41](/filings/0001683168-24-007729.md) | not reported | [0.19](/filings/0001683168-25-003436.md) | [0.19](/filings/0001683168-25-005901.md) | [0.20](/filings/0001683168-25-008144.md) | not reported | [0.19](/filings/0001683168-26-003607.md) | [0.20](/filings/0001683168-26-006096.md) | [0.20](/filings/0001683168-25-008144.md) | not reported | [0.24](/filings/0001683168-26-003607.md) | [0.27](/filings/0001683168-26-006096.md) |
| Basic EPS | $ per share | [0.49](/filings/0001683168-24-007729.md) | not reported | [0.22](/filings/0001683168-25-003436.md) | [0.22](/filings/0001683168-25-005901.md) | [0.22](/filings/0001683168-25-008144.md) | not reported | [0.22](/filings/0001683168-26-003607.md) | [0.22](/filings/0001683168-26-006096.md) | [0.22](/filings/0001683168-25-008144.md) | not reported | [0.25](/filings/0001683168-26-003607.md) | [0.29](/filings/0001683168-26-006096.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [8.3](/filings/0001683168-23-007808.md) | [6.2](/filings/0001683168-25-001548.md) | [13.2](/filings/0001683168-24-003234.md) | [9.8](/filings/0001683168-24-005366.md) | [8.1](/filings/0001683168-24-007729.md) | [11.7](/filings/0001683168-26-001856.md) | [29.8](/filings/0001683168-25-003436.md) | [15.8](/filings/0001683168-25-005901.md) | [9.4](/filings/0001683168-25-008144.md) | [6.3](/filings/0001683168-26-006096.md) | [6.9](/filings/0001683168-26-003607.md) | [7.5](/filings/0001683168-26-006096.md) |
| Total assets | $m | [2,881](/filings/0001683168-23-007808.md) | [2,904](/filings/0001683168-25-001548.md) | [3,007](/filings/0001683168-24-003234.md) | [3,287](/filings/0001683168-24-005366.md) | [3,463](/filings/0001683168-24-007729.md) | [3,494](/filings/0001683168-26-001856.md) | [3,674](/filings/0001683168-25-003436.md) | [3,764](/filings/0001683168-25-005901.md) | [3,810](/filings/0001683168-25-008144.md) | [3,858](/filings/0001683168-26-006096.md) | [4,053](/filings/0001683168-26-003607.md) | [4,422](/filings/0001683168-26-006096.md) |
| Total liabilities | $m | [2,615](/filings/0001683168-23-007808.md) | [2,629](/filings/0001683168-25-001548.md) | [2,727](/filings/0001683168-24-003234.md) | [3,006](/filings/0001683168-24-005366.md) | [3,178](/filings/0001683168-24-007729.md) | [3,201](/filings/0001683168-26-001856.md) | [3,375](/filings/0001683168-25-003436.md) | [3,461](/filings/0001683168-25-005901.md) | [3,502](/filings/0001683168-25-008144.md) | [3,549](/filings/0001683168-26-006096.md) | [3,738](/filings/0001683168-26-003607.md) | [4,103](/filings/0001683168-26-006096.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [266](/filings/0001683168-24-007729.md) | [275](/filings/0001683168-26-001856.md) | [279](/filings/0001683168-25-003436.md) | [280](/filings/0001683168-25-005901.md) | [285](/filings/0001683168-25-008144.md) | [0.0](/filings/0001683168-26-006096.md) | [0.0](/filings/0001683168-26-006096.md) | [303](/filings/0001683168-26-006096.md) | [308](/filings/0001683168-25-008144.md) | [310](/filings/0001683168-26-006096.md) | [314](/filings/0001683168-26-003607.md) | [319](/filings/0001683168-26-006096.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [61.3 d](/filings/0001683168-24-007729.md) | [56.1 d](/filings/0001683168-26-001856.md) | [52.7](/filings/0001683168-25-003436.md) | [43.3 d](/filings/0001683168-25-005901.md) | [69.8 d](/filings/0001683168-25-008144.md) | [68.0 d](/filings/0001683168-26-001856.md) | [73.9](/filings/0001683168-26-003607.md) | [54.5 d](/filings/0001683168-26-006096.md) | [84.9 d](/filings/0001683168-25-008144.md) | [75.8 d](/filings/0001683168-26-001856.md) | [83.8](/filings/0001683168-26-003607.md) | [106 d](/filings/0001683168-26-006096.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001683168-24-007729.md) | [0.3 d](/filings/0001683168-26-001856.md) | [0.1](/filings/0001683168-25-003436.md) | [0.1 d](/filings/0001683168-25-005901.md) | [0.1 d](/filings/0001683168-25-008144.md) | [0.1 d](/filings/0001683168-26-001856.md) | [0.5](/filings/0001683168-26-003607.md) | [0.1 d](/filings/0001683168-26-006096.md) | [0.0 d](/filings/0001683168-25-008144.md) | [0.1 d](/filings/0001683168-26-001856.md) | [0.8](/filings/0001683168-26-003607.md) | [0.2 d](/filings/0001683168-26-006096.md) |
| Share repurchases | $m | [0.7 d](/filings/0001683168-24-007729.md) | [1.2 d](/filings/0001683168-26-001856.md) | [1.7](/filings/0001683168-25-003436.md) | [9.5 d](/filings/0001683168-25-005901.md) | [1.7 d](/filings/0001683168-25-008144.md) | [0.0 d](/filings/0001683168-26-001856.md) | [0.0](/filings/0001683168-26-003607.md) | [5.1 d](/filings/0001683168-26-006096.md) | [1.0 d](/filings/0001683168-25-008144.md) | [2.6 d](/filings/0001683168-26-001856.md) | [1.2](/filings/0001683168-26-003607.md) | [2.5 d](/filings/0001683168-26-006096.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [26.7](/filings/0001683168-23-007808.md) | [25.4](/filings/0001683168-24-003234.md) | [25.4](/filings/0001683168-24-005366.md) | [25.2](/filings/0001683168-24-007729.md) | [24.6](/filings/0001683168-25-003436.md) | [24.3](/filings/0001683168-25-005901.md) | [24.2](/filings/0001683168-25-008144.md) | [24.3](/filings/0001683168-26-003607.md) | [24.2](/filings/0001683168-26-006096.md) | [24.0](/filings/0001683168-25-008144.md) | [23.5](/filings/0001683168-26-003607.md) | [23.5](/filings/0001683168-26-006096.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 21,554,714 at 2026-07-24, from the cover of the [10-Q filed 2026-08-07](/filings/0001683168-26-006096.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.